Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Luca Degli Esposti, Chiara Veronesi, Domenica Daniela Ancona, Margherita Andretta, Fausto Bartolini, Alberto Drei, Alessandro Lupi, Stefano Palcic, Davide Re, Francesca Vittoria Rizzi, Elisa Giacomini & Valentina Perrone. (2022) Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy. ClinicoEconomics and Outcomes Research 14, pages 139-147.
Read now
Read now
Sajita Setia, Nicola J Ryan, Prasad S Nair, Elma Ching & Kannan Subramaniam. (2018) Evolving role of pharmaceutical physicians in medical evidence and education. Advances in Medical Education and Practice 9, pages 777-790.
Read now
Read now
Articles from other publishers (31)
Julia Brandts & Kausik K. Ray. 2024. Clinical Lipidology. Clinical Lipidology
193
204.e1
.
Julia Brandts & Kausik K. Ray. (2023) Novel and future lipid-modulating therapies for the prevention of cardiovascular disease. Nature Reviews Cardiology 20:9, pages 600-616.
Crossref
Crossref
Mark J. Butler, Anne-Marie N. Romain, Rumisha Augustin, Patrick Robles, Ciaran P. Friel, Frank Vicari, Thevaa Chandereng, Catherine M. Alfano, Ying-Kuen Cheung & Karina W. Davidson. (2023) The effect of a multi-component behavior change technique intervention on physical activity among individuals on primary prevention statin therapy: A dose-finding trial protocol. Contemporary Clinical Trials 130, pages 107205.
Crossref
Crossref
Matthew T. Mefford, Matt Zhou, Hui Zhou, Hananeh Derakhshan, Teresa N. Harrison, Mona Zia, Michael H. Kanter, Ronald D. Scott, Tracy M. Imley, Mark A. Sanders, Royann Timmins & Kristi Reynolds. (2023) Safety Net Program to Improve Statin Initiation Among Adults With High Low-Density Lipoprotein Cholesterol. American Journal of Preventive Medicine.
Crossref
Crossref
Roberto F E Pedretti, Dominique Hansen, Marco Ambrosetti, Maria Back, Thomas Berger, Mariana Cordeiro Ferreira, Véronique Cornelissen, Constantinos H Davos, Wolfram Doehner, Carmen de Pablo y Zarzosa, Ines Frederix, Andrea Greco, Donata Kurpas, Matthias Michal, Elena Osto, Susanne S Pedersen, Rita Esmeralda Salvador, Maria Simonenko, Patrizia Steca, David R Thompson, Matthias Wilhelm & Ana Abreu. (2023) How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology. European Journal of Preventive Cardiology 30:2, pages 149-166.
Crossref
Crossref
Julia Brandts, Marlo Verket & Dirk Müller-Wieland. (2022) Lipidsenkung: neue Substanzen und neue KonzepteLipid lowering: new agents and new concepts. Herz 47:5, pages 419-425.
Crossref
Crossref
Kristen M. Tecson, Aaron Y. Kluger, Andrea E. Cassidy-Bushrow, Bin Liu, Chad M. Coleman, Laney K. Jones, Celeena R. Jefferson, Jeffrey J. VanWormer & Peter A. McCullough. (2022) Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events. The American Journal of Cardiology 176, pages 37-42.
Crossref
Crossref
Havva Yaglioglu, Duygu Eryavuz Onmaz, Sedat Abusoglu, Kenan Erdem, Abdullah Sivrikaya, Gulsum Abusoglu & Ali Unlu. (2022) New steps in acute coronary syndrome and antihyperlipidemic treatment: Determination of statins and metabolites by liquid chromatography tandem mass spectrometry. Biomedical Chromatography 36:8.
Crossref
Crossref
Carlos A Aguilar-Salinas, Rita A Gómez-Díaz & Pablo Corral. (2022) New Therapies for Primary Hyperlipidemia. The Journal of Clinical Endocrinology & Metabolism 107:5, pages 1216-1224.
Crossref
Crossref
Zhen-Vin Lee & Ho Lam. (2022) Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?. AsiaIntervention 8:1, pages 24-31.
Crossref
Crossref
Nicole A. Osbaugh & Sarah J. Billups. (2021)
A shared
decision‐making
intervention by pharmacy students to improve statin adherence
. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:1, pages 34-41.
Crossref
Crossref
Antonella Riva, Giovanna Petrangolini, Pietro Allegrini, Simone Perna, Attilio Giacosa, Gabriella Peroni, Milena Anna Faliva, Maurizio Naso & Mariangela Rondanelli. (2021) Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia. Nutrients 14:1, pages 108.
Crossref
Crossref
Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, Olav Jansen, Gustav Fraedrich, Harald Mudra, Werner Hacke, Peter Arthur Ringleb, D. Böckler, M. Böhm, H. Brückmann, E. S. Debus, J. Fiehler, W. Lang, K. Mathias, E. B. Ringelstein, J. Schmidli, R. Stingele & R. Zahn. (2021) Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2). Neurological Research and Practice 3:1.
Crossref
Crossref
Laney K. Jones, Stephanie Tilberry, Christina Gregor, Lauren H. Yaeger, Yirui Hu, Amy C. Sturm, Terry L. Seaton, Thomas J. Waltz, Alanna K. Rahm, Anne Goldberg, Ross C. Brownson, Samuel S. Gidding, Marc S. Williams & Michael R. Gionfriddo. (2021) Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis. Implementation Science 16:1.
Crossref
Crossref
Khalid Mehmood, Afrasim Moin, Talib Hussain, Syed Mohd Danish Rizvi, DV Gowda, Shazi Shakil & MA Kamal. (2021) Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?. Folia Microbiologica 66:6, pages 897-916.
Crossref
Crossref
Alexandra Fowler, Maureen Sampson, Alan T. Remaley & Bryce Chackerian. (2021) A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice. Vaccine 39:40, pages 5780-5786.
Crossref
Crossref
Ingo Ahrens, Artak Khachatryan, Bondo Monga, Eugen Dornstauder & Eduard Sidelnikov. (2021) Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany. Advances in Therapy 38:5, pages 2532-2541.
Crossref
Crossref
Stefanos Zafeiropoulos, Ioannis Farmakis, Anastasios Kartas, Alexandra Arvanitaki, Areti Pagiantza, Aristi Boulmpou, Athina Tampaki, Diamantis Kosmidis, Vassileios Nevras, Eleftherios Markidis, Ioannis Papadimitriou, Anastasia Vlachou, Konstantinos Arvanitakis, Santiago J. Miyara, Antonios Ziakas, Ernesto P. Molmenti, George Kassimis, Stavros Zanos, Haralambos Karvounis & George Giannakoulas. (2021) Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial. Atherosclerosis 323, pages 37-43.
Crossref
Crossref
Barak Zafrir, Aya Egbaria, Nili Stein, Avishay Elis & Walid Saliba. (2021) PCSK9 inhibition in clinical practice: Treatment patterns and attainment of lipid goals in a large health maintenance organization. Journal of Clinical Lipidology 15:1, pages 202-211.e2.
Crossref
Crossref
Gerald F. Watts, Alberico L. Catapano, Luis Masana, Alberto Zambon, Angela Pirillo & Lale Tokgözoğlu. (2020) Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients. Atherosclerosis Supplements 42, pages e30-e34.
Crossref
Crossref
Ping Siu Kee, Paul Ken Leong Chin, Martin A. Kennedy & Simran D. S. Maggo. (2020) Pharmacogenetics of Statin-Induced Myotoxicity. Frontiers in Genetics 11.
Crossref
Crossref
Phillip Lo, Katherine Kearney, Christopher A. Muir, Ning Song, John A. Eisman & Peter S. Macdonald. (2020) Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation. AACE Clinical Case Reports 6:5, pages e269-e272.
Crossref
Crossref
Lucas Borges Pereira, Ana Maria Rosa Freato Gonçalves, Camila Stéfani Estancial Fernandes, Andréia Turmina Fontanella, Priscila Maria Stolses Bergamo Francisco, Sotero Serrate Mengue, Rogério Boff Borges, Tatiane da Silva Dal Pizzol & Karen Sarmento Costa. (2020) Use of drugs for gastrointestinal disorders: evidence from National Survey on Access, Use and Promotion of Rational Use of Medicines. Einstein (São Paulo) 18.
Crossref
Crossref
João Paulo Vilela Rodrigues, Lucas Borges Pereira, Maria Olívia Barboza Zanetti, Andréia Turmina Fontanella, Nereida Kilza da Costa Lima, Sotero Serrate Mengue & Leonardo Régis Leira Pereira. (2020) Use of statins for the secondary prevention of stroke: are we respecting the scientific evidences?. Journal of Stroke and Cerebrovascular Diseases 29:8, pages 104912.
Crossref
Crossref
Jihad K. Shakarneh, Hussein O. Hallak, Heba B. Awadallah, Dua'a H. Al‐Hamed & Maher R. Khdour. (2020) Necessity and concerns about lipid‐lowering medical treatments and risk factors for non‐adherence: A cross‐sectional study in Palestine. International Journal of Clinical Practice 74:7.
Crossref
Crossref
Elena Olmastroni, Mezio T. Boccalari, Elena Tragni, Federico Rea, Luca Merlino, Giovanni Corrao, Alberico L. Catapano & Manuela Casula. (2020) Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies. Pharmacological Research 155, pages 104514.
Crossref
Crossref
Borut Jug, Breda Barbič-Žagar, Mateja Grošelj, Darja Milovanović Jarh & Tjaša Lipušček. (2020) Non-Interventional Study of Efficacy and Safety of Rosuvastatin Therapy and Introduction of Additional Doses to Clinical Practice in Patients with Hyperlipidemia. Cardiologia Croatica 15:3-4, pages 75-79.
Crossref
Crossref
Lee M. Tatham, Neill J. Liptrott, Steve P. Rannard & Andrew Owen. (2019) Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?. Molecules 24:15, pages 2685.
Crossref
Crossref
Mark McClellan, Nancy Brown, Robert M. Califf & John J. Warner. (2019) Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation 139:9.
Crossref
Crossref
Natalia Pătraşcu. (2019) Adherence and compliance to statin therapy – unresoved issues, solvable issues and myths. Farmacist.ro 4:189, pages 38.
Crossref
Crossref
Sony TutejaDaniel J. Rader. (2018)
SLCO1B1
and Statin Therapy
. Circulation: Genomic and Precision Medicine 11:9.
Crossref
Crossref